BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23

• Press Releases

  BioNTech Provides Update on Phase 2/3 Clinical Trial for mRNA Cancer Immunotherapy Candidate BNT113 in Metastatic HPV16-positive Head and Neck Cancer

  October 13, 2026

   · 

  9 min read
• Press Releases

  Bluejay Achieves Toray Contractual Manufacturing Milestone, Advancing Supply-Chain Resilience and Commercialization Readiness

  October 13, 2026

   · 

  5 min read
• Press Releases

  Cyted Health to Present U.S. Clinical Validation Data for the EndoSign® Barrett’s Esophagus Test in Late-Breaking Plenary Session at ACG 2026

  October 13, 2026

   · 

  2 min read
• Press Releases

  Merck Showcases First-Time Pivotal Phase 3 Results From Oncology Pipeline and Continued Innovative Potential of Existing Portfolio at ESMO 2026

  October 13, 2026

   · 

  19 min read
• Press Releases

  Mammogen Appoints Diagnostics Industry Leader, Dr. Robert S. Epstein, to Board of Directors

  October 13, 2026

   · 

  3 min read
• Press Releases

  Prelude Announces Clinical Trial Collaboration and Supply Agreement with Lilly to Evaluate KAT6A Selective Degrader PRT13722 in Combination with Verzenio® and Inluriyo® in Patients with HR+/HER2- Breast Cancer

  October 13, 2026

   · 

  6 min read
• Press Releases

  VERAXA Biotech Presents in vivo Proof-of-Concept Data for BiTAC®-ADC Technology at World ADC Congress

  October 13, 2026

   · 

  6 min read
• Press Releases

  Entera Presents Markedly Enhanced Anabolic Effects of EB613 (First-in-Class Oral PTH(1-34) Tablet) in Postmenopausal Women with Osteoporosis at High Risk of Fracture and Showcases Phase 3 Design at ASBMR 2026 Annual Meeting

  October 13, 2026

   · 

  11 min read
• Press Releases

  Visara Expands Ophthalmology Pipeline with Exclusive License for Investigational Nerve Growth Factor Therapy for Neurotrophic Keratitis

  October 13, 2026

   · 

  9 min read
• Press Releases

  Opus Genetics to Present at the Chardan Annual Healthcare Conference 2026

  October 13, 2026

   · 

  1 min read